Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases
Beta-adrenoceptor Activation Reduces Host Viral Resistance by Preventing IFN-γ Production in Liver NK Cells
Experimental Study Shows that Learned Immunosuppressive Placebo Responses Attenuate Disease Progression in a Rat Model of Arthritis
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Antibiotics through Effects on the Microbiota-Gut-Brain Axis and Inflammatory Monocytes May Reshape Brain Hippocampal NeurogenesisApril 18, 2017
Blocking IL-12 and IL-23 in APPPS1 Mouse Model Shows Promise as an Experimental Therapeutic Approach to Alzheimer’s DiseaseFebruary 13, 2015
Interleukin-33 Reverses Cognitive Deficits in Alzheimer’s Mouse Model Showing Promise as a Therapeutic TargetApril 27, 2016
Large Population Study Links Stress in Middle Age Women to Dementia and Alzheimer’s Risk Decades LaterJune 7, 2014
Aducanumab Shows Promise and Impressive Effects in Reducing Alzheimer’s Amyloid-β PlaquesOctober 5, 2016
Drug Companies and NIH in $230 Million Joint Project for Alzheimer’s, Diabetes, Lupus and ArthritisMarch 5, 2014
Julianne Moore Performing in Alzheimer’s Drama ‘Still Alice’ Wins Hollywood Actress AwardNovember 25, 2014
Massachusetts Neuroscience Consortium: A Collaborative Model between Government, Academia and IndustryNovember 19, 2013
